Synapticure

Synapticure delivers comprehensive virtual specialty care for patients and caregivers living with neurodegenerative diseases such as ALS, Alzheimer's, Parkinson's, and Huntington’s. Its teleneurology model provides access to expert neurologists, behavioral health providers, genetic testing guidance, clinical trial navigation and wraparound support in all U.S. states. The company partners with major health systems and payers—including CMS' GUIDE dementia program—and has rapidly scaled since its launch in early 2022 to serve thousands of patients nationwide. It does not develop therapeutics but connects patients to emerging treatments and trials.